WorldCare's Blinded Independent Central Review (BICR) process brings consistency to endpoint adjudication for clinical trials
Boston, MA, May 1, 2015 -- WorldCare
Clinical (WCC), one of the world's leading imaging CROs focused on maximizing the precision and accuracy of independent endpoint assessments in clinical trials, today announced that WCC President Dr. Rick Walovitch will present "Adjudicating Endpoints - The Case
for a Blinded Independent Central Review" at the Endpoint Adjudication
Conference in Philadelphia on May 5, 2015.
"Safety and efficacy endpoint assessment is a natural evolution of our
imaging services," stated Aaron Timm, CEO of WCC. "For example, Oncology trials often require
independent assessments by radiologists, pathologists and oncologists. We understand how to efficiently couple
imaging data with clinical data in a digital process that allows for multiple
independent assessment teams. We believe
our endpoint assessment offering minimizes interpretation variability which can
enable sponsors to maximize their chances of regulatory success. We look forward to sharing our insights at the
Endpoint Adjudication Conference."
In order to maximize the precision and
accuracy of data interpretation, WCC uniformly trains the subspecialty-trained,
board-certified experts who perform all of WCC's adjudication assessments. For more than 20 years, WCC has managed
endpoint assessment committees, including adjudication of both imaging and
non-imaging endpoints. WCC offers
multiple standing safety committees as well as efficacy adjudication for all
WorldCare Clinical is a global imaging
CRO that employs scientific expertise, innovative technology, and operational
excellence to maximize the precision and accuracy of a blinded independent
central review of Phase I – IV clinical trial data. The company has worked with
thousands of sites in more than 60 countries. WCC's robust technology platform
processes over 250 million images annually (CT, MRI, X-Ray, Echo, US, PET).
Originally founded in 1992 by the Massachusetts General Hospital (MGH)
Department of Radiology, WorldCare Clinical today is a Proscan Imaging
company. With over 400 employees
worldwide supporting WorldCare Clinical's mission, the company continues to
maintain a strategic relationship with the Harvard Hospital System as well as
other leading academic institutions.
For more information on WCC's services,
please visit our website at www.wcclinical.com